Aimei Health Technology (NASDAQ:AFJK) Shares Down 0.1% – Time to Sell?

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK)’s share price was down 0.1% during trading on Wednesday . The stock traded as low as $12.15 and last traded at $12.2550. Approximately 46,711 shares traded hands during mid-day trading, an increase of 72% from the average daily volume of 27,092 shares. The stock had previously closed at $12.27.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Aimei Health Technology from a “sell (d+)” rating to a “sell (d)” rating in a report on Friday, August 21st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Aimei Health Technology has a consensus rating of “Sell”.

Aimei Health Technology Price Performance

The business has a 50 day simple moving average of $13.29 and a 200 day simple moving average of $27.81. The stock has a market cap of $38.99 million, a PE ratio of 205.03 and a beta of 0.85.

Aimei Health Technology (NASDAQ:AFJK) last posted its earnings results on Thursday, August 13th. The company reported ($0.03) earnings per share for the quarter.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Jane Street Group LLC purchased a new position in Aimei Health Technology during the fourth quarter valued at approximately $302,000. Geode Capital Management LLC bought a new position in shares of Aimei Health Technology during the 4th quarter worth approximately $413,000. Quarry LP boosted its position in shares of Aimei Health Technology by 6.4% in the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock worth $1,891,000 after purchasing an additional 10,000 shares in the last quarter. Finally, Clear Street Group Inc. raised its position in shares of Aimei Health Technology by 36.5% in the 4th quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock valued at $5,334,000 after purchasing an additional 22,294 shares during the last quarter. Hedge funds and other institutional investors own 45.58% of the company’s stock.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.